What stocks are rated strong buy

It has made the most of the recent economic environment to maximize risk-adjusted returns compared to other stocks. While past performance is just an indication -- not a guarantee -- we believe this fund is among the most likely to deliver superior performance relative to risk in the future as well. B Good - The stock has a good track record for balancing performance with risk. Compared to other stocks, it has achieved above-average returns given the level of risk in its underlying investments.

2 “Strong Buy” Stocks With Solid Long-Term Upside

Backtested performance is not an indicator of future actual results. The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained. Backtested results are calculated by the retroactive application of a model constructed on the basis of historical data and based on assumptions integral to the model which may or may not be testable and are subject to losses.

General assumptions include: XYZ firm would have been able to purchase the securities recommended by the model and the markets were sufficiently liquid to permit all trading. Changes in these assumptions may have a material impact on the backtested returns presented.

Certain assumptions have been made for modeling purposes and are unlikely to be realized. No representations and warranties are made as to the reasonableness of the assumptions. This information is provided for illustrative purposes only. Backtested performance is developed with the benefit of hindsight and has inherent limitations. Specifically, backtested results do not reflect actual trading or the effect of material economic and market factors on the decision-making process.

Since trades have not actually been executed, results may have under- or over-compensated for the impact, if any, of certain market factors, such as lack of liquidity, and may not reflect the impact that certain economic or market factors may have had on the decision-making process.

Further, backtesting allows the security selection methodology to be adjusted until past returns are maximized.

Actual performance may differ significantly from backtested performance. Backtested results are adjusted to reflect the reinvestment of dividends and other income and, except where otherwise indicated, are presented gross-of fees and do not include the effect of backtested transaction costs, management fees, performance fees or expenses, if applicable.

Please note all regulatory considerations regarding the presentation of fees must be taken into account. No cash balance or cash flow is included in the calculation. Investment Criteria Stock Rating. Market Cap. Most Recommended Stocks Stock Rating. Select columns. Download to Excel.

Ascendis Pharma A/S (NASDAQ:ASND). Argenx SE (NASDAQ:ARGX).

The following is a guide to the stock-research ratings systems used by the brokerage firms covered by MarketWatch. Because ratings terms vary from firm to firm, the guide is designed to help investors understand the meaning behind each rating where available and to allow them to make comparisons between each firm's recommendation. Some brokerages turned down MarketWatch's requests for their rating descriptions. For analysts' current ratings changes and other research click here. Sectors carry weightings of overweight: Expected to outperform the broader market averages; market weight: Expected to equal performance of broader market averages; underweight: expected to underperform broader market averages.

The second quarter of started with a slide in the markets, as the glum mood came after President Trump acknowledged publicly that the first two weeks of April are likely to see a rise in deaths from COVID, as the epidemic intensifies. In one way, this is to be expected — the disease has an incubation period up to 14 days, and course of illness lasting up to 14 cases, in cases with notable symptoms.

Backtested performance is not an indicator of future actual results. The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained. Backtested results are calculated by the retroactive application of a model constructed on the basis of historical data and based on assumptions integral to the model which may or may not be testable and are subject to losses.

Analysts' Top Stocks

Today, though, U. With this in mind, investors are buckling down and bracing for sustained volatility. According to the analysts, a select few are not only sturdy enough to weather the storm, but are also set up for noteworthy long-term growth to the upside, specifically pointing to the payments industry. Add in hefty upside potential and you have two compelling investment opportunities. Global Payments GPN. As one of the leading payment processors, Global Payments offers effective payments and software solutions that simplify commerce and help companies of all sizes achieve success.

This browser is not supported. Please use another browser to view this site.

All rights reserved. It has since been updated to include the most relevant information available. For investors prepared to put in the work, there are plenty of gems to be found. I set out to pinpoint some of the hottest stocks to buy on the Street right now using the best analysts on Wall Street as guidance. TipRanks tracks and measures the performance of over 4, analysts, enabling investors to identify consistently outperforming experts. Analysts are ranked based on two crucial factors: success rate and average return-per-recommendation. Following top analysts is an easy way to identify hot stocks to buy that experts believe have strong investing potential. Looking at TipRanks best-performing analysts, FB stock is expected to see more upside, despite tremendous growth already. He has calculated that Boeing actually has a trade-war exposure of just And in this case, despite all the trade war noise, I would recommend carefully considering Boeing.

All rights reserved. What do all investors have in common?

Last year was a rough one for investors, with markets turning in their worst performance in 10 years. And volatility promises to be a constant challenge for investors in

Top Rated Stocks

All rights reserved. This is especially true of the healthcare space, which has managed to hold up significantly better than other industries. Source: Shutterstock. The first of our healthcare stocks to buy is Ascendis Pharma. Adding to the good news, there was a positive effect on renal calcium resorption. We would expect dose tailoring on an individual basis, as would occur in practice vs. See the ARGX stock analysis. FOLD expects to see commercial sales from Latin American countries in to further drive topline growth. To top it all off, GTx pipeline development is continuing. As for the rest of the Street, other analysts are in agreement.

7 “Strong Buy” Healthcare Stocks to Buy Now

The MarketWatch News Department was not involved in the creation of this content. Most of this week, our writers have discussed penny stocks that hit it big this year. Check out some of these in our articles:. The fact of the matter is that the vat majority actually have shown potential. Trillium Therapeutics Inc.